Inventor · disambiguated record
Herbert Faleck
Also filed as: FALECK HERBERT · FALECK HERBERT J
7 granted patents·25 pending applications·103 citations·filing 2001–2020
86Inventor score
Top patents by PatentIndex Score
32 records- 0193US7115631B2Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidateCELGENE CORP·Filed 2002·Granted Oct 3, 2006·39 cites·56 claims
- 0292US8460650B2Treatment of inflammatory diseases using placental stem cellsEDINGER JAMES W·Filed 2008·Granted Jun 11, 2013·17 cites·28 claims
- 0391US6486177B2Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidateCELGENE CORP·Filed 2001·Granted Nov 26, 2002·31 cites·46 claims
- 0484US8753883B2Treatment of psoriasis using placental stem cellsEDINGER JAMES W·Filed 2011·Granted Jun 17, 2014·5 cites·7 claims
- 0579US8916146B2Treatment of inflammatory diseases using placental stem cellsANTHROGENESIS CORP·Filed 2013·Granted Dec 23, 2014·2 cites·18 claims
- 0676US7612096B2Methods for treatment, modification and management of radiculopathy using 1-oxo-2-(2,6-dioxopiperidin-3yl)-4-aminoisoindolineCELGENE CORP·Filed 2004·Granted Nov 3, 2009·9 cites·17 claims
- 0772US11723930B2Treatment of inflammatory diseases using placental stem cellsCELULARITY INC·Filed 2020·Granted Aug 15, 2023·0 cites·5 claims
- 0870US2010093797A1Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo MethylphenidateZELDIS JEROME B·Filed 2009·Application pending·0 cites
- 0965US2015190433A1Treatment of inflammatory diseases using placental stem cellsANTHROGENESIS CORP·Filed 2014·Application pending·0 cites
- 1064US2013158073A1Methods Of Diminishing Co-Abuse PotentialKHETANI VIKRAM·Filed 2013·Application pending·0 cites
- 1163US2009062336A1Methods of Diminishing Co-Abuse PotentialCELGENE CORP·Filed 2008·Application pending·0 cites
- 1262US2012136028A1Methods Of Diminishing Co-Abuse PotentialKHETANI VIKRAM·Filed 2012·Application pending·0 cites
- 1361US2013053414A1Methods for treatment of cognitive and menopausal disorders with d-threo methylphenidateZELDIS JEROME B·Filed 2012·Application pending·0 cites
- 1460US2017007648A1Treatment of inflammatory diseases using placental stem cellsANTHROGENESIS CORP·Filed 2016·Application pending·0 cites
- 1559US2006183774A1Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidateCELGENE CORP·Filed 2006·Application pending·0 cites
- 1658US2011257227A1Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo MethylphenidateZELDIS JEROME B·Filed 2011·Application pending·0 cites
- 1757US2008227816A1Methods and compositions using immunomodulatory compounds for the treatment and management of central nervous system disorders or diseasesCELGENE CORP·Filed 2008·Application pending·0 cites
- 1857US2004204456A1Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidateCELGENE CORP·Filed 2004·Application pending·0 cites
- 1955US2005239830A1Methods of diminishing co-abuse potentialKHETANI VIKRAM·Filed 2004·Application pending·0 cites
- 2054US2005143344A1Methods and compositions using immunomodulatory compounds for the treatment and management of central nervous system disorders or diseasesFiled 2004·Application pending·0 cites
- 2153US2010143312A1Treatment of diseases, disorders or conditions of the lung using placental cellsHARIRI ROBERT J·Filed 2009·Application pending·0 cites
- 2251US2007161696A1Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of painZELDIS JEROME B·Filed 2004·Application pending·0 cites
- 2350US2009155207A1Use of Immunomodulatory Compounds for the Treatment of Transverse Myelitis, Multiple Sclerosis, and Other DisordersHARIRI ROBERT J·Filed 2008·Application pending·0 cites
- 2448US2005182097A1Methods and compositions using thalidomide for the treatment and management of central nervous system disorders or diseasesFiled 2004·Application pending·0 cites
- 2547US2005119194A1Methods of using and compositions comprising thalidomide for treatment, modification and management of fibromyalgiaFiled 2004·Application pending·0 cites
- 2639US2004087642A1Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of painFiled 2003·Application pending·0 cites
- 2739US2004087558A1Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of painFiled 2003·Application pending·0 cites
- 2839US2006122179A1Methods and compositions using JNK inhibitors for treatment and management of central nervous system injuryZELDIS JEROME B·Filed 2005·Application pending·0 cites
- 2939US2005203142A1Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of painFiled 2003·Application pending·0 cites
- 3039US2006106085A1Methods and compositions using PDE4 modulators for treatment and management of central nervous system injuryZELDIS JEROME B·Filed 2005·Application pending·0 cites
- 3139US2006122228A1Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injuryZELDIS JEROME B·Filed 2005·Application pending·0 cites
- 3238US2005222209A1Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with diseaseZELDIS JEROME B·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Herbert Faleck files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →